Literature DB >> 8306067

Solubilization and characterization of GABAB receptor binding sites from porcine brain synaptic membranes.

M Facklam1, N G Bowery.   

Abstract

1. The characteristics of membrane bound GABAB receptors in pig brain are similar to those in rat brain as judged by in vitro binding experiments and sensitivity to GTP. The rank order of affinity of GABAB receptor ligands was CGP 54626 > GABA approximately (-)-baclofen >> CGP 35348 = CGP 36742 > (+)-baclofen in membranes from both species. 2. For solubilization of GABAB receptors from pig brain, washed membranes were preincubated with 5 mM MgSO4 and subsequently incubated with various detergents. 3-[(3-Cholamidopropyl)dimethyl-ammoniol]-1-propane sulphonate (CHAPS) (0.5%) proved to be the most successful, solubilizing 22.7 +/- 4.7% (mean +/- s.e. mean, n = 6) of GABAB receptors. 3. Binding of [3H]-GABA to GABAB receptors solubilized with 0.5% CHAPS exhibited similar characteristics to the binding at membrane bound receptors since, firstly, the Kd and Bmax values (around 30 nM and 450 fmol mg-1 protein, respectively) were comparable; secondly, stereospecific binding for baclofen was obtained in both forms; thirdly, the affinity for the agonists GABA and (-)-baclofen and the antagonists CGP 35348, CGP 36742 and CGP 54626 were the same; fourthly, comparable sensitivity to Ca2+ (2.5 mM) was observed and finally, a similar sensitivity to GTP was apparent. 4. Saturation experiments performed with the GABAB antagonist, [3H]-CGP 54626, indicated a higher Kd value and a lower Bmax value for solubilized (7.7 +/- 2.6 nM and 1033 +/- 41 fmol mg-1 protein, mean +/- s.e. mean, n = 3) than for membrane bound receptors (1.35 +/- 0.08 nM, 1171 +/- 20 fmol mg-1 protein, n = 3).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8306067      PMCID: PMC2175871          DOI: 10.1111/j.1476-5381.1993.tb13958.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

Review 1.  Reverse intrinsic activity of antagonists on G protein-coupled receptors.

Authors:  W Schütz; M Freissmuth
Journal:  Trends Pharmacol Sci       Date:  1992-10       Impact factor: 14.819

2.  Are increases in GABAB receptors consistent findings following chronic antidepressant administration?

Authors:  J A Cross; R W Horton
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

3.  Effect of a protracted antidepressant treatment on signal transduction and [3H](-)-baclofen binding at GABAB receptors.

Authors:  A M Szekely; M L Barbaccia; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1987-10       Impact factor: 4.030

4.  Prevention of the agonist binding to gamma-aminobutyric acid B receptors by guanine nucleotides and islet-activating protein, pertussis toxin, in bovine cerebral cortex. Possible coupling of the toxin-sensitive GTP-binding proteins to receptors.

Authors:  T Asano; M Ui; N Ogasawara
Journal:  J Biol Chem       Date:  1985-10-15       Impact factor: 5.157

5.  Regional effects of pertussis toxin in vivo and in vitro on GABAB receptor binding in rat brain.

Authors:  C Knott; J J Maguire; R Moratalla; N G Bowery
Journal:  Neuroscience       Date:  1993-01       Impact factor: 3.590

Review 6.  GABAB receptor pharmacology.

Authors:  N G Bowery
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

8.  Solubilization and partial purification of GABAB receptor from bovine brain.

Authors:  Y Ohmori; K Kuriyama
Journal:  Biochem Biophys Res Commun       Date:  1990-10-15       Impact factor: 3.575

9.  Functional coupling of the gamma-aminobutyric acidB receptor with calcium ion channel and GTP-binding protein and its alteration following solubilization of the gamma-aminobutyric acidB receptor.

Authors:  Y Ohmori; M Hirouchi; J Taguchi; K Kuriyama
Journal:  J Neurochem       Date:  1990-01       Impact factor: 5.372

10.  Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.

Authors:  V Ramkumar; G L Stiles
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

View more
  2 in total

1.  Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain.

Authors:  Maria Frosini; Casilde Sesti; Stefania Dragoni; Massimo Valoti; Mitri Palmi; Henry B F Dixon; Fabrizio Machetti; Giampietro Sgaragli
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

2.  Effects of repeated administration of baclofen to rats on GABAB receptor binding sites and subunit expression in the brain.

Authors:  Anders Lehmann; Jan P Mattsson; Anders Edlund; Thore Johansson; A Jonas Ekstrand
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.